行情中心 沪深A股 上证指数 板块行情 股市异动 股圈 专题 涨跌情报站 盯盘 港股 研究所 直播 股票开户 智能选股
全球指数
数据中心 资金流向 龙虎榜 融资融券 沪深港通 比价数据 研报数据 公告掘金 新股申购 大宗交易 业绩速递 科技龙头指数

CHANGYU-B(200869):EXPECT A MILD RECOVERY IN 2013

中国国际金融有限公司 2013-04-23

张裕B --%

FY12 results review

Changyu reported 2012 NP of Rmb1,701mn (-10.8% YoY) andrevenue of Rmb5,644mn (-6.4% YoY). The sluggish performancewas caused by the negative impact of the government crackdown onlavish spending, imported wines and the “pesticide incident” in3Q12. Sales of Castel (-18% YoY) and Cabernet (-7% YoY) werehit the hardest. Brandy sales +13.4% to reach Rmb859mn.Gross margin squeezed 0.6ppt to 69.5% due to raw material priceincrease, product mix downgrade and deleveraging on smaller salesvolume. SG&A exp./sales ratio expanded 1.3ppts to 30.2% mainlydue to marketing and promotion investment (especially in 3Q12)and higher staff costs. Final dividend was Rmb754mn (44.3%payout ratio).

Factors to watch

Earnings could halt decline in 1Q although sales could still postnegative growth thanks to cost controls. 1Q sales could still facepressure given that the central government’s anti-corruptioncampaign could still affect sales of high-end wines in the N-T andindustry competition is still fierce. Margin-wise, we expect a lowerSG&A exp./sales ratio considering some one-off marketingexpenses to tackle negative news in 3Q12 and expenses related tothe Changyu’s 120th anniversary last year.

Expect mild recovery from 2Q. Going forwards, we expect fastertop line growth in coming quarters considering the improvingeconomic environment and 2H’s easier base. Brandy couldcontribute more sales in FY13, while the launch of three newChateau wines are expected to compensate for the weak Castelsales. The company’s efforts to improve product value-for-moneycould be also positive to sales volume. For 2013, we expect 6%/7%sales/earnings given still tough competitive landscape. Grossmargin is expected to squeeze due to lower mix but could be offsetby decrease in SG&A/sales ratio.

Valuation and recommendations

We maintain our BUY rating given the company’s recovery outlookfrom 2013 and cheap valuation. We cut FY13/14e earnings by7%/11% and trim our end-2013 TP from HK$57.7 to HK$52.8. TheB-share is trading at 10.7x 2013e EPS vs. its historical average of18.3x and the F&B average of 21.3x. Risks includelower-than-expected industry growth.

免责声明:以上内容仅供您参考和学习使用,任何投资建议均不作为您的投资依据;您需自主做出决策,自行承担风险和损失。九方智投提醒您,市场有风险,投资需谨慎。

相关股票

相关板块

  • 板块名称
  • 最新价
  • 涨跌幅

相关资讯

扫码下载

九方智投app

扫码关注

九方智投公众号

头条热搜

涨幅排行榜

  • 上证A股
  • 深证A股
  • 科创板
  • 排名
  • 股票名称
  • 最新价
  • 涨跌幅
  • 股圈